Summary of best response after the first extended dose delay of belamaf. (A-B) Post hoc analysis of DREAMM-7 (A) and DREAMM-8 (B) evaluating best response in patients on treatment before the first extended dose delay and after the first extended dose delay at any time (left graph) or after 1 to 2 doses (right graph). The first extended dose delay was defined as lasting >2 cycles, which in DREAMM-7 was >42 days and in DREAMM-8 was >56 days. CR, complete response; MR, minimal response; NE, not evaluable; PD, progressive disease; sCR, stringent complete response; SD, stable disease; VGPR, very good PR.